Search Results 1 – 20 of 360
Fostemsavir (Rukobia, FTR)
Pre-exposure Prophylaxis (PrEP) to Prevent HIV During Periconception, Antepartum, and Postpartum Periods
Herpes (HHV-8/CMV)
Fostemsavir
Cabotegravir
What to Start: Initial Combination Regimens for the Antiretroviral-Naive Patient
Protease Inhibitor-Based Regimens
Table 9. Advantages and Disadvantages of Antiretroviral Components Recommended as Initial Antiretroviral Therapy
Other Antiretroviral Regimens for Initial Therapy When Abacavir, Tenofovir Alafenamide, and Tenofovir Disoproxil Fumarate Cannot Be Used or Are Not Optimal
Table 7. Antiretroviral Regimen Considerations for Initial Therapy Based on Specific Clinical Scenarios
Non-Nucleoside Reverse Transcriptase Inhibitor-Based Regimens
Integrase Strand Transfer Inhibitor–Based Regimens
Nucleoside Reverse Transcriptase Inhibitor Options as Part of Initial Therapy
Drug Interactions Between HIV-1 gp120-Directed Attachment Inhibitors and Other Drugs (Including Antiretroviral Agents)
Table 10. Antiretroviral Components or Regimens Not Recommended as Initial Therapy
All Archived Guidelines
Adult and Adolescent ARV Archive
Adult and Adolescent Opportunistic Infection Archive
Pediatric ARV Archive
Pediatric Opportunistic Infection Archive